AI assistant
Sending…
RESMED INC — Director's Dealing 2023
Nov 21, 2023
30071_dirs_2023-11-20_01d43b4a-67cc-4172-b7f3-a44e921f3bc2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2023-11-20
Reporting Person: Douglas Robert Andrew (President and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-20 | ResMed Common Stock | F | 1375.219 | $148.94 | Disposed | 13849 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 250525 | Indirect |
Footnotes
F1: Disposition to issuer for tax withholding on vesting of Performance Restricted Stock Units granted on 11/19/2020.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29